Summary of COVID-19 clevudine studies

1. Song et al., Oral antiviral clevudine compared with placebo in Korean COVID-19 patients with moderate severity

61 patient clevudine late treatment RCT: 744% worse recovery (p=0.16) and 27% improved viral clearance (p=0.56).
RCT 61 moderate COVID-19 patients in Korea showing no significant difference in viral clearance or clinical outcomes with clevudine compared to placebo.
Dec 2021, medRxiv, https://www.medrxiv.org/content/10.1101/2021.12.09.21267566, https://c19p.org/song10